BioRegen Biomedical (Changzhou) Co., Ltd.

The Division was founded on 28 April 2008 by Dr. Shu Xiaoqheng, a well-known scientist, and is a high-technology enterprise with autonomous research and development capabilities, using self-connected Self-Crosslinked & Biometic Biomaterials as a technical platform. The main operation is the development, production and marketing of new biomedical materials and pharmaceutical aberrations to address the difficult needs of clinical units such as five branches, gynaecology and obstetrics and general surgery. It has a beautiful vision and a noble mission: to rejuvenate traumatized organizations. Berage has developed a series of post-operative functional healing materials that are needed for five government departments, gynaecology and obstetrics, and has successfully entered the pharmaceutical markets of developed countries such as beauty, ethics, English, French and Italian。

Translated from the manufacturer's own website. Source